InNexus Biotechnology (InNexus Biotechnology) LT-Debt-to-Total-Asset : 0.08 (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. InNexus Biotechnology's long-term debt to total assests ratio for the quarter that ended in Mar. 2011 was 0.08.

InNexus Biotechnology's long-term debt to total assets ratio increased from Mar. 2010 (0.00) to Mar. 2011 (0.08). It may suggest that InNexus Biotechnology is progressively becoming more dependent on debt to grow their business.

InNexus Biotechnology LT-Debt-to-Total-Asset Historical Data

The historical data trend for InNexus Biotechnology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology LT-Debt-to-Total-Asset Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.55

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	0.11	0.10	0.08

InNexus Biotechnology LT-Debt-to-Total-Asset Calculation

InNexus Biotechnology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2010 is calculated as

LT Debt to Total Assets (A: Jun. 2010 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2010 )	/	Total Assets (A: Jun. 2010 )
	=	0	/	3.312
	=

InNexus Biotechnology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2011 is calculated as

LT Debt to Total Assets (Q: Mar. 2011 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2011 )	/	Total Assets (Q: Mar. 2011 )
	=	0.269	/	3.237
	=

InNexus Biotechnology (GREY:IXSBF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

InNexus Biotechnology LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines